Arkolith/Insider Trading/INDV/Form 4

Ciaffoni Joseph

Chief Executive Officer, DirectorIndivior Pharmaceuticals, Inc. (INDV) · full profile →Form 4 · filed Jun 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 22, 2026Option exercise(M)1.3M——1.4M
Jun 22, 2026Tax withholding(F)613K$38.32$23.5M790K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 22, 2026Option exercise(M)1.3M——0

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001443841-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML